Zdena Tuháčková
-
Inhibition of mTORC1 by SU6656, the Selective Src Kinase Inhibitor, Is Not Accompanied by Activation of Akt/PKB Signalling in Melanoma Cells
L. Ondrušová, J. Réda, P. Žáková, Zdena Tuháčková
2013, Vol. 59, Issue 4, pp. 162-167 -
Molecular Therapeutics Lessons from the Role of Src in Cellular Signalling
Zdena Tuháčková
2005, Vol. 51, Issue 4, pp. 114-120
